Sanofi (SNY) Cash from Operations (2009 - 2026)

Sanofi (SNY) has 10 years of Cash from Operations data on file, last reported at 1970364929.08 in Q1 2026.

• Quarterly Cash from Operations fell 10.5% year-over-year to 1970364929.08 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 23402913526.15 (up 5.27% YoY) and the FY2025 annual result came in at 12513467783.01, up 28.95% from the prior year.
• Cash from Operations slipped to 1970364929.08 in Q1 2026 per SNY's latest filing, from 11237676090.9 in the prior quarter.
• The five-year high for Cash from Operations was 11967679607.6 in Q4 2023, with the low at 95599835.5 in Q1 2024.
• Average Cash from Operations over 5 years is 5156115640.0, with a median of 3057316838.85 recorded in 2022.
• Year-over-year, Cash from Operations plunged 96.76% in 2024 and soared 2202.93% in 2025.
• Sanofi's Cash from Operations stood at 11195174339.4 in 2022, then rose by 6.9% to 11967679607.6 in 2023, then retreated by 12.22% to 10505361379.0 in 2024, then climbed by 6.97% to 11237676090.9 in 2025, then plunged by 82.47% to 1970364929.08 in 2026.
• Business Quant data shows SNY's Cash from Operations at 1970364929.08 in Q1 2026, 11237676090.9 in Q4 2025, and 8539947442.32 in Q3 2025.